[Wilson disease].
Nagai
Youji
Y
Mito General Hospital, Hitachi, Ltd.
D000251:Adenosine Triphosphatases / Q000235:genetics; D027682:Cation Transport Proteins / Q000235:genetics; D002614:Chelating Agents / Q000627:therapeutic use; D000073840:Copper-Transporting ATPases; D006527:Hepatolenticular Degeneration / Q000175:diagnosis / Q000209:etiology / Q000523:psychology / Q000628:therapy; D006801:Humans; D016031:Liver Transplantation; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D009154:Mutation; D011613:Psychotherapy; D015032:Zinc / Q000627:therapeutic use
D027682:Cation Transport Proteins; D002614:Chelating Agents; D009125:Muscle Relaxants, Central; D000251:Adenosine Triphosphatases; D000073840:Copper-Transporting ATPases; D015032:Zinc